UCL Technology Fund

UCL Technology Fund is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, focusing particularly on the physical and life sciences. The Fund supports UCL in achieving the full potential of innovations that have prospects for outstanding societal and market impact, right through the development journey from initial proof of concept to practical commercial application.

Managed by AlbionVC, one of the largest independent venture capital investors in the UK, in collaboration with UCL Business, the Fund has been investing in commercialisation opportunities from UCL since 2016. It has invested in 25 portfolio companies, 15 licensing projects, and 19 proof-of-concept investments, with 4 companies achieving Nasdaq IPOs.

The Fund's unique approach includes early-stage proof-of-concept funding, development funding, and support for company formation, aiming to help UCL innovators scale globally. Notable portfolio companies include Better Origin, Bloomsbury AI, Bramble Energy, Hazy, Intrinsic Semiconductor Technologies, MediaGamma, and Orchard Therapeutics.